BI
GILD icon

Boulegeris Investments’s Gilead Sciences GILD Stock Holding History

Boulegeris Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-20,582
Closed -$1.4M – 53
2017
Q1 		$1.4M Sell
20,582
-36,995
-64% -$2.6M 0.84% 20
2016
Q4 		$4.12M Sell
57,577
-16,484
-22% -$1.23M 2.51% 10
2016
Q3 		$5.86M Buy
74,061
+700
+1% +$56.9K 3.71% 8
2016
Q2 		$6.12M Buy
73,361
+235
+0.3% +$20.9K 4.16% 8
2016
Q1 		$6.72M Buy
73,126
+508
+0.7% +$45.8K 4.73% 7
2015
Q4 		$7.35M Sell
72,618
-387
-0.5% -$40.3K 5.33% 6
2015
Q3 		$7.17M Buy
73,005
+2,332
+3% +$259K 5.48% 5
2015
Q2 		$8.27M Buy
70,673
+2,578
+4% +$282K 5.94% 5
2015
Q1 		$6.68M Buy
68,095
+545
+0.8% +$55.3K 4.92% 6
2014
Q4 		$6.37M Buy
67,550
+13,460
+25% +$1.39M 5.07% 8
2014
Q3 		$5.76M Buy
+54,090
New +$5.3M 4.7% 8

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boulegeris Investments's GILD Position: Q2 2017 in Review

Boulegeris Investments sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 20,582 shares — an estimated $1.4M sold.

Boulegeris Investments first reported a position in GILD in Q3 2014 and held it in 11 quarters. The position peaked at $8.27M in Q2 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Boulegeris Investments reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Boulegeris Investments sold 20,582 Gilead Sciences shares in Q2 2017, an estimated $1.4M.
  • Boulegeris Investments first reported a position in Gilead Sciences in Q3 2014 and held it in 11 quarters.
  • Boulegeris Investments's Gilead Sciences position peaked at $8.27M in Q2 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Boulegeris Investments's 13F filing for Q2 2017, filed 8 Aug 2017.